Enzyme Target Shows Promise as Pancreatic Cancer Therapy

Newsfeed Image, Light Gray Text On Dark Gray Background
Pancreatic cancer—the third leading cause of cancer-related deaths—with incidence rates that mirror the increase in obesity. The survival rate for pancreatic cancer is only 8% or 9%, highlighting the need for new treatment options.

Targeting an enzyme that tumors harness to dispose of nitrogen has shown promise as a novel approach to treating pancreatic cancer, according to a study published by Nature Communications.  Read more . . .